Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030195
Filing Date
2014-05-14
Accepted
2014-05-14 10:36:26
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v377964_10q.htm 10-Q 363361
2 EXHIBIT 31 v377964_ex31.htm EX-31 7301
3 EXHIBIT 32 v377964_ex32.htm EX-32 4869
4 GRAPHIC tpg16.jpg GRAPHIC 47311
  Complete submission text file 0001144204-14-030195.txt   3411521

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iccc-20140331.xml EX-101.INS 433358
6 XBRL TAXONOMY EXTENSION SCHEMA iccc-20140331.xsd EX-101.SCH 37357
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20140331_cal.xml EX-101.CAL 40593
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20140331_def.xml EX-101.DEF 157990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20140331_lab.xml EX-101.LAB 237512
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20140331_pre.xml EX-101.PRE 200494
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 14839744
SIC: 2835 In Vitro & In Vivo Diagnostic Substances